Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,292,509
+$853,955 QoQ
Shares Held
25,006
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#1,178
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DT Investment Partners, LLC holds $27,488,762 across 12 Drug Manufacturers - General names. ABBV ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
55,162 | $14,009,493 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,006 | $6,292,509 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,995 | $3,982,857 | |
| 4 | LLY |
ELI LILLY & Co
|
1,645 | $1,973,062 | |
| 5 | AMGN |
Amgen Inc
|
1,181 | $427,663 | |
| 6 | PFE |
Pfizer Inc
|
12,779 | $307,718 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,180 | $275,421 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,383 | $137,308 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,292,509 | 25,006 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,438,554 | 25,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,535,499 | 28,603 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,622,738 | 28,603 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,309,288 | 28,603 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $6,045,699 | 28,855 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,127,533 | 28,855 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $6,093,245 | 30,855 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,247,654 | 30,595 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $5,207,149 | 28,595 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,431,367 | 28,595 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,262,370 | 28,595 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,852,604 | 28,595 | Shares | Sole | 2023-08-28 | |
| 2023-03-31 | $4,557,185 | 28,595 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,621,237 | 28,595 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,569,314 | 26,595 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,226,143 | 27,593 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $4,473,101 | 27,593 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,624,658 | 26,770 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,938,702 | 27,243 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,181,967 | 28,249 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $3,057,106 | 28,249 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,900,550 | 27,070 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $2,371,061 | 27,070 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,714,873 | 27,652 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,106,805 | 27,652 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||